{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T20:39:45Z","timestamp":1768768785704,"version":"3.49.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008228","name":"Madurai Kamaraj University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008228","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejphar.2021.173899","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T09:31:16Z","timestamp":1611739876000},"page":"173899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study"],"prefix":"10.1016","volume":"896","author":[{"given":"Rahul","family":"Parit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar","family":"Jayavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.173899_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biopha.2017.05.062","article-title":"ACE-2\/Ang1-7\/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats","volume":"92","author":"Abuohashish","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.ejphar.2021.173899_bib2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1291\/hypres.29.865","article-title":"Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme","volume":"29","author":"Agata","year":"2006","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2021.173899_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1113\/expphysiol.2007.040345","article-title":"Genetically altered animal models for mas and angiotensin-(1\u20137)","volume":"93","author":"Alenina","year":"2008","journal-title":"Exp. Physiol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173899_bib4","first-page":"891","article-title":"The Middle East respiratory syndrome (MERS)","volume":"33","author":"Azhar","year":"2019","journal-title":"Infect. Dis. Clin."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","article-title":"ACE2, angiotensin-(1\u20137), and Mas: the other side of the coin","volume":"465","author":"Bader","year":"2013","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2021.173899_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lfs.2016.04.013","article-title":"Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis","volume":"153","author":"Bai","year":"2016","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/hc0302.103712","article-title":"Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice","volume":"105","author":"Bendall","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/hy1101.093423","article-title":"NADH\/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat","volume":"38","author":"Beswick","year":"2001","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cvr\/cvr036","article-title":"Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit","volume":"91","author":"Bodiga","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"16","key":"10.1016\/j.ejphar.2021.173899_bib10","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5001\/omj.2010.49","article-title":"An overview of clinical pharmacology of Ibuprofen","volume":"25","author":"Bushra","year":"2010","journal-title":"Oman Med. J."},{"key":"10.1016\/j.ejphar.2021.173899_bib12","series-title":"The Angiotensin-(1-7) Axis","first-page":"1","article-title":"formation and metabolism pathways","author":"Chappell","year":"2019"},{"key":"10.1016\/j.ejphar.2021.173899_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fendo.2016.00030","article-title":"Adipose tissue remodeling: its role in energy metabolism and metabolic disorders","volume":"7","author":"Choe","year":"2016","journal-title":"Front. Endocrinol."},{"issue":"7","key":"10.1016\/j.ejphar.2021.173899_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/CS20130291","article-title":"Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress","volume":"126","author":"Clarke","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"issue":"9","key":"10.1016\/j.ejphar.2021.173899_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040644","article-title":"Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review","volume":"10","author":"Dambha-Miller","year":"2020","journal-title":"BMJ. Open."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173899_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/01.RES.0000205761.22353.5f","article-title":"Angiotensin-converting enzyme II in the heart and the kidney","volume":"98","author":"Danilczyk","year":"2006","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41416-018-0372-7","article-title":"Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs","volume":"120","author":"Dell'Omo","year":"2019","journal-title":"Br. J. Canc."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib18","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"Novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","article-title":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","volume":"38","author":"Esler","year":"2020","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173899_bib20","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1530\/JOE-13-0516","article-title":"Interplay between the immune system and adipose tissue in obesity","volume":"223","author":"Exley","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2021.173899_bib21","first-page":"6920620","article-title":"Liraglutide enhances the activity of the ACE-2\/ang(1-7)\/mas receptor pathway in lungs of male pups from food-restricted mothers and prevents the reduction of SP-A","author":"Fandi\u00f1o","year":"2018","journal-title":"Internet J. Endocrinol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173899_bib22","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib23","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","article-title":"Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors","volume":"68","author":"Ferrario","year":"2005","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.ejphar.2021.173899_bib24","doi-asserted-by":"crossref","first-page":"H2373","DOI":"10.1152\/ajpheart.00426.2008","article-title":"Regulation of ACE2 in cardiac myocytes and fibroblasts","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.ejphar.2021.173899_bib25","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib26","doi-asserted-by":"crossref","first-page":"E205","DOI":"10.1152\/ajpendo.00053.2015","article-title":"Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis","volume":"309","author":"Grant","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173899_bib27","doi-asserted-by":"crossref","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","article-title":"Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)","volume":"292","author":"Grobe","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173899_bib28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2021.173899_bib29","doi-asserted-by":"crossref","first-page":"8794","DOI":"10.1038\/srep08794","article-title":"Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy","volume":"5","author":"Hao","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173899_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"13","key":"10.1016\/j.ejphar.2021.173899_bib31","doi-asserted-by":"crossref","first-page":"108199","DOI":"10.1016\/j.celrep.2020.108199","article-title":"Activation of the SARS-CoV-2 receptor Ace2 by cytokines through pan JAK-STAT enhancers during pregnancy","volume":"32","author":"Hennighausen","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173899_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib33","doi-asserted-by":"crossref","first-page":"H2166","DOI":"10.1152\/ajpheart.00061.2006","article-title":"Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats","volume":"291","author":"Jessup","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.ejphar.2021.173899_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038502","article-title":"ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production","volume":"7","author":"Jin","year":"2012","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.ejphar.2021.173899_bib35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.RES.0000187500.24964.7A","article-title":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients","volume":"97","author":"Keidar","year":"2005","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2021.173899_bib36","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors \u03b1 and\u2009\u03b3","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib37","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect. Dis. Poverty."},{"key":"10.1016\/j.ejphar.2021.173899_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.ejphar.2021.173899_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrendo.2009.101","article-title":"SIRT1 and insulin resistance","volume":"5","author":"Liang","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2021.173899_bib41","doi-asserted-by":"crossref","first-page":"107587","DOI":"10.1016\/j.pharmthera.2020.107587","article-title":"Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients","volume":"213","author":"Liu","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1113\/expphysiol.2012.067165","article-title":"Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats","volume":"98","author":"Lo","year":"2013","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2021.173899_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.110.167346","article-title":"An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats","volume":"57","author":"Marques","year":"2011","journal-title":"Hypertension"},{"issue":"13","key":"10.1016\/j.ejphar.2021.173899_bib45","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"11","key":"10.1016\/j.ejphar.2021.173899_bib46","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.184911","article-title":"Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart","volume":"103","author":"Mercure","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5527\/wjn.v4.i1.74","article-title":"ACE and ACE2 in kidney disease","volume":"4","author":"Mizuiri","year":"2015","journal-title":"World J. Nephrol."},{"issue":"10","key":"10.1016\/j.ejphar.2021.173899_bib48","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3899\/jrheum.200547","article-title":"Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in rheumatoid synovium","volume":"47","author":"Mokuda","year":"2020","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173899_bib49","doi-asserted-by":"crossref","first-page":"H1506","DOI":"10.1152\/ajpheart.00587.2011","article-title":"SIRT1-mediated acute cardioprotection","volume":"301","author":"Nadtochiy","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173899_bib50","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/HJH.0b013e3283440665","article-title":"Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1-9) axis in experimental hypertension","volume":"29","author":"Ocaranza","year":"2011","journal-title":"J. Hypertens."},{"issue":"18","key":"10.1016\/j.ejphar.2021.173899_bib51","first-page":"1775","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"323","author":"Onder","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1050-1738(02)00233-5","article-title":"The role of ACE2 in cardiovascular physiology","volume":"13","author":"Oudit","year":"2003","journal-title":"Trends Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","article-title":"Chappell M, Butany J, Backx PH, Tsushima RG, Scholey JW, Khokha R, Penninger JM. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice","volume":"75","author":"Oudit","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11897-011-0063-7","article-title":"Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy","volume":"8","author":"Oudit","year":"2011","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ejphar.2021.173899_bib55","doi-asserted-by":"crossref","first-page":"108146","DOI":"10.1016\/j.diabres.2020.108146","article-title":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?","volume":"163","author":"Pal","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"10","key":"10.1016\/j.ejphar.2021.173899_bib56","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/CIRCRESAHA.112.268029","article-title":"Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II\/AT1 receptor axis","volume":"110","author":"Patel","year":"2012","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2021.173899_bib57","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.112.191650","article-title":"Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice","volume":"59","author":"Patel","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2021.173899_bib58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.ejphar.2021.173899_bib59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173899_bib60","first-page":"2162","article-title":"Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches?","volume":"24","author":"Perrella","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2021.173899_bib61","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/infdis\/jiaa332","article-title":"ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19","volume":"222","author":"Pinto","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.carpath.2012.05.004","article-title":"Expression of angiotensin-converting enzyme 2 and its end product angiotensin 1-7 is increased in diabetic atheroma: implications for inflammation and neovascularization","volume":"22","author":"Purushothaman","year":"2013","journal-title":"Cardiovasc. Pathol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173899_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000375362","article-title":"Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats","volume":"131","author":"Qiao","year":"2015","journal-title":"Cardiology"},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib64","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.ejphar.2021.173899_bib65","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1210\/en.2014-1685","article-title":"Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats","volume":"156","author":"Roman\u00ed-P\u00e9rez","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2021.173899_bib66","series-title":"PPARs in the Renal Regulation of Systemic Blood Pressure","first-page":"698730","author":"Roszer","year":"2010"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173899_bib67","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/cts.12862","article-title":"Effect of common medications on the expression of SARS-CoV-2 entry receptors in kidney tissue","volume":"13","author":"Saheb Sharif-Askari","year":"2020","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib68","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.ejphar.2021.173899_bib69","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"9","key":"10.1016\/j.ejphar.2021.173899_bib70","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00004872-200409000-00022","article-title":"Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase","volume":"22","author":"Sarafidis","year":"2004","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib71","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00380-016-0936-5","article-title":"The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts","volume":"32","author":"Shin","year":"2017","journal-title":"Heart Ves."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173899_bib72","doi-asserted-by":"crossref","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","article-title":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan","volume":"296","author":"Soler","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/cvr\/cvr242","article-title":"ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension","volume":"92","author":"Sriramula","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2021.173899_bib74","author":"Takahashi"},{"issue":"4","key":"10.1016\/j.ejphar.2021.173899_bib75","doi-asserted-by":"crossref","first-page":"H1560","DOI":"10.1152\/ajpheart.00941.2004","article-title":"Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor","volume":"289","author":"Tallant","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2021.173899_bib76","doi-asserted-by":"crossref","first-page":"104792","DOI":"10.1016\/j.antiviral.2020.104792","article-title":"Coronavirus membrane fusion mechanism offers a potential target for antiviral development","volume":"178","author":"Tang","year":"2020","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib77","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/jcmm.13406","article-title":"CCAAT\/enhancer-binding protein \u03b2 overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes","volume":"22","author":"Tie","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2021.173899_bib78","first-page":"256294","article-title":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","author":"Tikellis","year":"2012","journal-title":"Int. J. Pept."},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib79","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bcp.2014.11.013","article-title":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications","volume":"93","author":"Tikoo","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"43","key":"10.1016\/j.ejphar.2021.173899_bib80","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.173899_bib81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1749-6632.2002.tb04262.x","article-title":"Hyperglycemia and insulin resistance: possible mechanisms","volume":"967","author":"Tom\u00e1s","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2021.173899_bib82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-12-801364-9.00025-0","article-title":"ACE2 cell biology, regulation, and physiological functions","author":"Turner","year":"2015","journal-title":"The protective arm of the renin angiotensin system (RAS). 2015"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173899_bib83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: from vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173899_bib84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.ejphar.2021.173899_bib85","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.173899_bib86","doi-asserted-by":"crossref","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.ejphar.2021.173899_bib87","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173899_bib88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.115.06892","article-title":"Angiotensin-converting enzyme 2 metabolizes and partially inactivates pyr-apelin-13 and apelin-17: physiological effects in the cardiovascular system","volume":"68","author":"Wang","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2021.173899_bib89","doi-asserted-by":"crossref","first-page":"m810","DOI":"10.1136\/bmj.m810","article-title":"Preventing a covid-19 pandemic","volume":"368","author":"Watkins","year":"2020","journal-title":"BMJ"},{"issue":"6483","key":"10.1016\/j.ejphar.2021.173899_bib91","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"7798","key":"10.1016\/j.ejphar.2021.173899_bib92","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ejphar.2021.173899_bib93","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice","volume":"55","author":"Wysocki","year":"2006","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.ejphar.2021.173899_bib94","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib95","first-page":"7624","article-title":"ACEIs\/ARBs for the prevention of type 2 diabetes in patients with cardiovasculardiseases: a systematic review and meta-analysis","volume":"9","author":"Xue-Ying","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib96","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib97","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbrc.2009.08.112","article-title":"Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta\/Smad signaling pathway in rabbits","volume":"389","author":"Zeng","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.ejphar.2021.173899_bib98","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.ejphar.2021.173899_bib99","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10557-015-6592-7","article-title":"Preservation of glucagon-like peptide-1 level attenuates angiotensin II-induced tissue fibrosis by altering AT1\/AT 2 receptor expression and angiotensin-converting enzyme 2 activity in rat heart","volume":"29","author":"Zhang","year":"2015","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2021.173899_bib100","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/22221751.2020.1729071","article-title":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejphar.2021.173899_bib101","author":"Zhang"},{"issue":"6","key":"10.1016\/j.ejphar.2021.173899_bib102","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4077\/CJP.2014.BAD268","article-title":"Alteration of cardiac ACE2\/Mas expression and cardiac remodelling in rats with aortic constriction","volume":"57","author":"Zhang","year":"2014","journal-title":"Chin. J. Physiol."},{"issue":"2","key":"10.1016\/j.ejphar.2021.173899_bib103","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","article-title":"A genomic perspective on the origin and emergence of SARS-CoV-2","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ejphar.2021.173899_bib104","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.ejphar.2021.173899_bib105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.HYP.0000146400.57221.74","article-title":"Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats","volume":"44","author":"Zhong","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2021.173899_bib106","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:12:32Z","timestamp":1762143152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":105,"alternative-id":["S0014299921000522"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173899","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173899"}}